Exhibit 107
Calculation Of Filing Fee Tables
Form S-8
(Form Type)
Iovance Biotherapeutics, Inc.
(Exact Name of Registrant as Specified in its Charter)
Table 1: Newly Registered Securities
| Security Type | | Security Class
Title | | Fee
Calculation
Rule | | Amount
Registered(1) | | | Proposed
Maximum
Offering
Price Per
Unit | | | Maximum
Aggregate
Offering Price | | | Fee Rate | | | Amount of
Registration
Fee | |
| Equity | | Common stock, par value $0.000041666 per share | | Rule 457(c) and Rule 457(h) | | | 750,000 | (2) | | $ | 12.79 | (3) | | $ | 9,592,500 | | | $ | 0.0000927 | | | $ | 889.22 | |
| Total Offering Amounts | | | | | | | | | | | | | | | $ | 889.22 | |
| Total Fee Offsets | | | | | | | | | | | | | | | | - | |
| Net Fee Due | | | | | | | | | | | | | | | $ | 889.22 | |
| | (1) | Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock that becomes issuable in respect of the securities identified in the above table by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the receipt of consideration that increases the number of the Registrant’s outstanding shares of common stock. |
| | (2) | Represents 750,000 additional shares of common stock reserved for issuance under the Registrant’s Amended and Restated 2021 Inducement Plan. |
| | (3) | Estimated in accordance with Rule 457(c) and (h) under the Securities Act solely for the purpose of calculating the registration fee on the basis of $12.79, the average of the high and low prices of the Registrant’s common stock as reported on The Nasdaq Global Market on March 8, 2022. |
